Copyright: ©Author(s) 2026.
World J Diabetes. Apr 15, 2026; 17(4): 115842
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.115842
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.115842
Table 3 The pathogenic role of the m.C15954T mutation
| Scoring criteria | m.C15954T mutation | Score/20 | Classification |
| More than one independent report | No | 0 | ≤ 6 points: Neutral polymorphisms; 7-10 points: Possibly pathogenic; 11-13 points (not including evidence from single fiber, steady-state level, or trans-mitochondrial cybrid studies): Probably pathogenic; ≥ 11 points (including evidence from single fiber, steady-state level or trans-mitochondrial cybrid studies): Definitely pathogenic |
| Evolutionary conservation of the base pair | No changes | 2 | |
| Variant heteroplasmy | No | 0 | |
| Segregation of the mutation with disease | Yes | 2 | |
| Biochemical defect in complex I, III or IV | Yes | 2 | |
| Evidence of mutation segregation with biochemical defect from single fiber studies | No evidence | 0 | |
| Mutant mt-tRNA steady-state level or evidence of pathogenicity in trans-mitochondrial cybrid studies | Strong evidence | 5 | |
| Maximum score | Definitely pathogenic | 11 |
- Citation: Xu L, Liu MT, He XM, Zhang SR, Yu DJ, Ding Y. Type 2 diabetes mellitus may be associated with a novel mitochondrial tRNAThr/tRNAPro mutation. World J Diabetes 2026; 17(4): 115842
- URL: https://www.wjgnet.com/1948-9358/full/v17/i4/115842.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i4.115842